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Abstract
Background: Globally, the HIV epidemic continues to represent a pressing public health issue in Europe and
elsewhere. There is an emerging and progressively urgent need to harmonise HIV and STI behavioural surveillance
among MSM across European countries through the adoption of common indicators, as well as the development
of trend analysis in order to monitor the HIV-STI epidemic over time. The Sialon II project protocols have been
elaborated for the purpose of implementing a large-scale bio-behavioural survey among MSM in Europe in line
with a Second Generation Surveillance System (SGSS) approach.
Methods/Design: Sialon II is a multi-centre biological and behavioural cross-sectional survey carried out across 13
European countries (Belgium, Bulgaria, Germany, Italy, Lithuania, Poland, Portugal, Romania, Slovakia, Slovenia, Spain,
Sweden, and the UK) in community settings. A total of 4,966 MSM were enrolled in the study (3,661 participants in
the TLS survey, 1,305 participants in the RDS survey). Three distinct components are foreseen in the study protocols:
first, a preliminary formative research in each participating country. Second, collection of primary data using two
sampling methods designed specifically for ‘hard-to-reach’ populations, namely Time Location Sampling (TLS) and
Respondent Driven Sampling (RDS). Third, implementation of a targeted HIV/STI prevention campaign in the
broader context of the data collection.
Discussion: Through the implementation of combined and targeted prevention complemented by meaningful
surveillance among MSM, Sialon II represents a unique opportunity to pilot a bio-behavioural survey in community
settings in line with the SGSS approach in a large number of EU countries. Data generated through this survey will
not only provide a valuable snapshot of the HIV epidemic in MSM but will also offer an important trend analysis of
the epidemiology of HIV and other STIs over time across Europe. Therefore, the Sialon II protocol and findings are likely
to contribute significantly to increasing the comparability of data in EU countries through the use of common indicators
and in contributing to the development of effective public health strategies and policies in areas of high need.
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Background
The HIV epidemic is still representing a pressing public
health issue worldwide and in Europe as well [1]. Current
documents published by the European Centre for Disease
Control (ECDC) and focusing on the WHO European
Region clarify that 136,235 new HIV diagnoses were re-
ported in 2013, with a rate of 15.7 per 100,000. A total of
1,715,434 infections diagnosed in the WHO European
Region represent the current number of persons leaving
with HIV.
In terms of transmission, according to the 2013 data,
the highest proportion of new HIV diagnoses was re-
ported in men who have sex with men (MSM): this spe-
cific sub-population accounts for 42 % of all new
infections in EU/EEA countries (compared to 40.4 % in
2012) [2].
For this specific population, in EU/EEA countries
where data are available, since 2004 HIV diagnoses have
increased by 33 %, confirming that MSM could be con-
sidered as a very high risk population for acquiring HIV,
as a considerable part of the new HIV infected people
across Europe is reported among this sub-population.
In addition, in younger MSM an increase of new
diagnoses is dramatically reported for the EU/EEA area:
between 2004 and 2013, the number of new HIV posi-
tive MSM aged 20-24 years almost doubled, whilst in
adult MSM (30–39 years old) the estimates remain rela-
tively stable. These high estimates (for the new diagnoses
in particular) could be partially due to increasing HIV
testing behaviours, but they could also indicate onward
transmission in this specific population. Indeed, with
regards the latter, according to the current scientific lit-
erature an increase of high risk sexual practices (such as
unprotected anal intercourse) has been reported among
MSM across Europe [1, 3]
In terms of serum-status awareness, almost one third
of those infected in Europe are estimated to be unaware
of their seropositive status [1].
Data seems to suggest that the current situation is
becoming increasingly critical from a public health
perspective.
Set within this context, HIV diagnosis has become a
key surveillance activity for monitoring the HIV epi-
demic especially in ‘hard-to-reach’ populations such as
MSM. Reliable data, including trends in risk behaviours
over time, are of crucial importance in order to under-
stand whether and by how much rates are increasing or
decreasing and which (sub-) populations are affected the
most. Consequently, the international literature, such as
UNAIDS and WHO reports and publications [4], have
stressed the need for public health to embrace three
main approaches in monitoring and controlling the
epidemic: (i) a structured surveillance system method;
(ii) the use of common set of indicators adopted across
Europe, and; (iii) specific prevention campaigns targeting
MSM and testing promotion as the cornerstone of the
HIV response.
In terms of structured surveillance initiatives and in
response to the growing awareness of the urgency for a
comprehensive and effective response, a number of
European countries have implemented surveys specific-
ally targeting MSM [5] focusing primarily on the moni-
toring of risk behaviours. However, a Second Generation
Surveillance System (SGSS) approach [4], whereby both
biological (e.g. oral fluid) and behavioural data (e.g. from
questionnaires) are collected and analysed jointly, has
only been adopted in a limited number of countries [6].
This is problematic and limits the value of such tar-
geted initiatives due to, amongst other things, a lack of
reliability and comparability of data at the European
level [7]. A SGSS approach is defined by the WHO as
the “regular, systematic collection, analysis and inter-
pretation of information for use in tracking and de-
scribing changes in the HIV/AIDS epidemic over time”
[8]. SGSS is important because it not only allows the
public health sector to monitor the spread of infections
in a given population and to analyse trends over time,
but it can also facilitate countries to improve their
planning and evaluation of prevention and treatment
activities.
With regards to the second approach (i.e. the use of a
common set of indicators adopted across Europe to
monitoring and controlling the epidemic), despite some
European countries adopting a SGSS approach, imple-
mentation is regrettably patchy and not systematic. Fur-
thermore, even where examples of a SGSS approach are
evident, there is often considerable variation between
countries in terms of specific indicators utilised and re-
ported. Such challenges highlight the need for HIV and
STI behavioural surveillance among MSM across EU
countries to be harmonised for high-risk population
such as MSM [5]. This call to action has been taken up by
the United Nations General Assembly in 2001, which in a
Special Session on HIV/AIDS proposed the construction
of a set of core indicators, namely the UNGASS indicators
[9, 10] to kick-start such harmonisation in the collection
of data at the international level. These UNGASS indi-
cators have been revised and updated periodically until
post-2012 when they became known as the Global
AIDS Response Progress Reporting (GARPR) indicators
(see [11] for the most recent guidelines, released at the
beginning of 2014).
In terms of the third approach (i.e. targeted prevention
campaigns), such specific HIV/STI prevention cam-
paigns targeting MSM and promoting testing represent
the cornerstone of the HIV response. Yet although many
EU Member States (public health sectors and voluntary/
third sectors) have routinely and for some time,
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implemented prevention programmes targeting MSM
specifically, current prevention and treatment strategies
appear to be not sufficient [12] . It has to be acknowl-
edged that the evidence-base for primary HIV preven-
tion does not reach the same degree of graded evidence
as bio-medical prevention approaches due to the com-
plexity of intertwined behavioural and structural factors.
This is not surprising given that health promotion and
public health interventions are complex, non-linear, and
multi-layered processes often with no simple measurable
outcomes. They are therefore difficult to evaluate, result-
ing in a general lack of evidence for which HIV pro-
grammes might be the most effective [13].
To-date, few studies have been able to address simul-
taneously all three of the approaches to tackling the HIV
epidemic as advocated by UNAIDS and the WHO. How-
ever, of those studies that have embraced such an ap-
proach, community-based surveys targeting MSM that
adopt bio-behavioural measures (e.g. oral fluid testing
for HIV and behavioural questionnaires) have found high
levels of HIV prevalence and risk behaviours (such as
unprotected anal intercourse) as well as critical levels of
HIV testing uptake considering the high frequency of un-
protected anal intercourse with different partners [14, 15].
Such studies continue to highlight the urgent need for
large-scale reliable and comparable second generation sur-
veillance data on MSM that are paired with meaningful
STI/HIV prevention, treatment and care.
Consequently, and in line with the most recent EC com-
munication on combating HIV/AIDS in the European
Union and neighbouring countries (2009–2013), the over-
all objective of the Sialon II project is to carry out and
promote combined and targeted HIV/STI prevention for
MSM complemented by second generation HIV/STI sur-
veillance in collaboration with UNAIDS and WHO. The
project is funded by the European Commission under the
Second Programme of Community Action in the Field of
Health (2008–2013). The Sialon II project is based on the
experiences and lessons learned from the former Sialon
project, funded under the 2003–2008 Public Health
Programme (Work Plan 2007) [15].
In this paper, the Sialon II project protocols are
presented which included three parts: (i) the formative
research phase (including prevention needs assessment)
with the objective to identify the specific community-
based settings to carry out data collection and to assess
local prevention needs; (ii) the use of innovative surveil-
lance methodologies with the objective to access ‘hard-
to-reach’ MSM in community-based settings; (iii) HIV
(HIV1/2) and STI (Syphilis and Hepatitis [HBV/HBC])
testing algorithms, the implementation of targeted pre-
vention activities with the objective to respond to im-
mediate prevention needs when conducting the data
collection.
Methods
The Sialon II project is a multi-centre biological and
behavioural cross-sectional survey carried out across 13
European countries including: Belgium, Bulgaria, Germany,
Italy, Lithuania, Poland, Portugal, Romania, Slovakia,
Slovenia, Spain, Sweden, and the UK. The survey has been
implemented using the same methodologies (protocols,
UNGASS/GARPR indicators, epidemiological algorithms)
and prevention strategies in each of the participating
countries. The project builds on an experienced, skilled,
and cohesive partnership founded through previous
collaborations across Europe. All partner institutions
are public bodies, representing either public health in-
stitutes or universities in their respective countries with
skilled and well-equipped laboratories ensuring capable
scientific and technical reporting. The Sialon II partner-
ship is rooted more broadly in a further network of
local collaborating partners ranging from universities,
teaching hospitals, epidemiological centres, gay and/or
HIV non-governmental organisations (NGOs) across all
participating countries. This extended network has been a
key resource for the project ensuring on the one hand,
relevant specialisation in HIV/STI research, and on the
other, suitability to social, cultural, policy and political
contexts in each country as well as actively enabling the
participation and views of the target group (MSM) to be
taken into account.
In what is to follow, the three related yet distinct compo-
nents (i.e. formative research; primary data collection;
targeted prevention activities) are described in more detail.
Formative research
During 2011–12, formative research (FR) was carried
out in all 13 participating countries. Information was
collected via a combination of a dedicated FR question-
naire and focused analysis of secondary data from the
European MSM Internet Survey (EMIS) [16, 17]. The FR
questionnaires were completed by each project partner
from the respective study country in partnership with
their local collaborating partner (e.g. NGO). Each ques-
tionnaire explored a number of areas such as: the pro-
posed study site; previous experiences with different
study methodologies and target groups; data on gay-
friendly commercial and non-commercial sites; testing
opportunities, regulations, and treatment guidelines for
HIV, STIs, HBV, and HCV; contextual factors such as le-
gislation relating to gay issues (e.g. date of homosexuality
becoming legal, possibility of gay marriage or officially
recognised civil partnerships, protection from discrimin-
ation regarding sexual orientation etc.) and stigmatisation.
In addition to the contextual information provided by the
country partner, EMIS data were also used to further char-
acterise the MSM population in each respective study
area. This allowed for compiling a comprehensive ‘picture’
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of each study area which described the relevant context,
in which the data collection took place, included informa-
tion such as demographic characteristics, proportions of
MSM among the adult population, as well as data such as
the degree of ‘out-ness’ reported by MSM in the study
area, self-reported internalised homo-negativity, gay-venue
attendance, and self-reported HIV and STI history.
During the FR process, gay-friendly commercial (e.g.
cafés, bars, discos, sex-clubs, saunas, porn-shops) and
gay friendly non-commercial sites (e.g. community cen-
tres and cruising areas) were described in detail using a
number of indicators such as the estimated number of
MSM attending the venue per day during a week, opening
hours, special events, logistical aspects for performing
sampling, opportunities for sexual contact in the venue,
availability of condoms, lubricants and other prevention
activities, and so on.
Findings from the FR were presented and discussed
during a dedicated study meeting with all network part-
ners present (including collaborating partners such as
NGOs). A FR report was compiled and provided to all
national study sites in order to better tailor both the
planned TLS and RDS surveys, as well as the targeted
prevention actions [17].
Primary data collection
Following, and informed by, the FR phase, a TLS survey
(3,661 participants) was planned and implemented during
2013–2014 in nine cities and countries: Belgium (Brussels),
Bulgaria (Sofia), Germany (Hamburg), Poland (Warsaw),
Portugal (Lisbon), Slovenia (Ljubljana), Spain (Barcelona),
Sweden (Stockholm), and the UK (Brighton). In the
remaining four partner countries, an RDS survey (1,305
participants) was planned and implemented in Italy
(Verona), Lithuania (Vilnius), Romania (Bucharest), and
Slovakia (Bratislava) (see Table 1 - Timeline in the Sialon
II study by sampling method and city; Table 2 - MSM
enrolled in the Sialon II study by sampling method and
city). In all cases the following inclusion criteria for MSM
participation were used: must have had any kind of sex
(oral or anal, penetrative or not) at least once with another
man during the previous 12 months; able to provide an-
onymous informed consent; agree to complete the study
questionnaire; agree to provide either an oral fluid sample
(for TLS) or blood sample (for RDS). Exclusion criteria
were: being younger than 18 years old, and having already
participated in the study.
Prior to biological sample collection in both TLS and
RDS study arms, informed consent was collected for
each participant. A self-administered pen-and-paper
questionnaire was then administered to all participants
to obtain data on: the social and cultural context of
respondents; behavioural data on sex practices; risk-
reduction strategies such as not having anal intercourse
with non-steady partners, condom use, and HIV serosta-
tus disclosure; STI history; self-reported serostatus, and
number and type of sexual partners. The questionnaire
was designed by the Sialon II network in line with the
GARPR indicators. A preliminary version of the ques-
tionnaire was piloted in each country with the collab-
oration of local gay and/or HIV NGOs. Subsequently,
a ‘final’ English version of the questionnaire was trans-
lated into each of the languages of the participating
countries and then back-translated into English for
quality control. The same questionnaire was used in
both surveys (TLS and RDS): in the TLS version add-
itional items were included focusing on the venues in
the given city (for weight calculations), whilst in the
RDS survey extra items were used in order to assess
the network size of the participants.
Table 1 Timeline in the Sialon II study by sampling method and city
Sampling method City and Country Starting month Ending month
Time-Location Sampling (TLS) Brussels, Belgium April 2013 July 2013
Sofia, Bulgaria July 2013 September 2013
Hamburg, Germany April 2013 August 2013
Warsaw, Poland May 2013 September 2013
Lisbon, Portugal April 2013 August 2013
Ljubljana, Slovenia May 2013 October 2013
Barcelona, Spain May 2013 June 2013
Stockholm, Sweden May 2013 August 2013
Brighton, UK April 2013 June 2013
Respondent-Driven Sampling (RDS) Verona, Italy June 2013 June 2014
Vilnius, Lithuania June 2013 August 2014
Bratislava, Slovakia June 2013 August 2014
Bucharest, Romania February 2014 November 2014
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In both surveys, in line with the project protocol, a
unique identification number (barcode) was used in
order to identify each questionnaire and to link the be-
havioural information with the biological data (e.g. oral
fluid). This approach was used in order (i) to guarantee
the privacy/anonymity of the participants and (ii) to
minimise the potential for any mistakes in linking the
different types of information (bio-behavioural in both
TLS and RDS survey.
Time-location sampling
TLS has been used successfully in previous studies and
has demonstrated to be an effective and reliable method
for gathering both behavioural and biological data in
‘hard-to-reach’ populations [14, 15, 18–20]. Based on as-
sumption of an HIV prevalence in the study population
of at most 15 % based on results from the previous
Sialon project, a precision of 5 %, a significance level of
95 % and a design effect of 2, a random clustered sample
size of 392 MSM per city was calculated. Taking into
account the possibility of invalid samples, a final target
of n = 408 per city was planned.
With regards to venues and participants eligibility, any
physical public or private locations attended by MSM
could be included as venues in the universe (e.g. commer-
cial venues such as cafés, discos/clubs, bars, sex shop, sex
cinema, saunas, spas etc. as well as non-commercial
venues such as cruising settings and special events). One
exception were venues that specifically serve HIV positive
members of the priority population, since including these
types of venues would artificially increase representation
of HIV positive individuals in the final sample. Virtual
meeting places such as websites and smartphone apps
were not included.
In order to finalise the sampling frame, once the initial
list of venues or initial universe of venues was elaborated
based on the findings of the formative research, MSM
venues and venue-day-time (VDT) units were identified
and two sampling frames constructed [19]. The first
sampling frame (or venues sampling frame) comprised a
list of venues that met the attendance requirements and
were willing to participate (eligible venues). The second
sampling frame (VDT sampling frame) comprised a list
of venue-specific sampling periods of four hours each
(VDT). In constructing this second frame, for each
venue and for each day of the week, the VDT units were
determined according to two key criteria: i) logistical
feasibility and safety for data collectors; and ii) VDTs
were expected to yield at least 10 eligible MSM. Conse-
quently, at this stage some venues identified previously
as being potential data collection sites were excluded
due to various reasons such as low levels of attendance of
eligible MSM participants, specific attendance patterns,
and/or operational barriers or lack of permission by the
venue owners/manager.
Where possible, in order to verify characteristics of
potentially eligible VDTs, project partners and/or their
collaborating partners (e.g. NGOs) interviewed the re-
spective venue owners. This process also allowed (where
necessary) the counting of MSM attending the VDT by
use of a ‘clicker’ (Type I Enumeration) [21] assuming
that most attendees would be eligible. In order to dis-
cern venue specific sampling periods, standardised enu-
merations were conducted of the MSM attending venues
during possible high attendance day-time periods. The
result of this process was the creation of the final VDT
sampling frame. As data collection proceeded, these
sampling frames were then updated on a monthly basis
(e.g. where new venues may have opened, others closed,
or the VDT proved to be unproductive).
Following completion of the final sampling frame, a
three-stage sampling plan to select venues, VDTs, and
participants was used. Based on the monthly sampling
frames, a set of venues equal to the number of sampling
events planned for the upcoming month were randomly
selected (stage 1 of randomisation). Selected venues
were then sorted in ascending order of VDTs beginning
with the venue with the least number of VDTs (which is
less flexible for scheduling on the calendar); one VDT
was selected from this venue (stage 2 of randomisation).
The VDT selected was scheduled on the calendar by
choosing any available day on which the VDT falls. After
this sampling event was scheduled, a VDT was selected
randomly for the next venue. The process was repeated
for each venue selected in first stage of randomisation.
Stage 1 and 2 of randomisation were carried out in two
Table 2 MSM enrolled in the Sialon II study by sampling
method and city
Sampling method City and country Overall sample
Time-Location Sampling (TLS) Brussels, Belgium 406
Sofia, Bulgaria 411
Hamburg, Germany 408
Warsaw, Poland 408
Lisbon, Portugal 409
Ljubljana, Slovenia 416
Barcelona, Spain 408
Stockholm, Sweden 377
Brighton, UK 418
Respondent-Driven
Sampling (RDS)
Verona, Italy 400
Vilnius, Lithuania 322
Bratislava, Slovakia 400
Bucharest, Romania 183
TOTAL 4.966
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independent steps because if they had combined in only
one step, the venues with many VDTs would have been
more likely to be selected than those with fewer VDTs.
In addition to venues, each country could also select
purposefully up to a maximum of three events to
schedule into the sampling calendar (infrequent events
to attract members of the target population e.g. gay
pride), and thus were excluded from the sampling
frame. As the sampling calendar was filled, if the se-
lected VDT could not be scheduled because there were
no days available in any week of the month in question,
a new VDT was selected randomly from the remaining
VDTs of that venue. If no VDT from that venue could
be scheduled in any week of the month, then another
venue was selected randomly from the set of venues
not chosen in stage 1, until the sampling-event was
filled. If there was no choice, overlapping VDTs were
scheduled.
More VDTs than needed were scheduled as alterna-
tives VDTs. When data collectors did not achieve the
sample size in the primary venue they could go to an
alternative VDT until they had reached the sample size.
Alternatives VDTs were scheduled in different days
and/or timetable. They also were chosen randomly to
minimise selection bias. If an event was cancelled be-
fore their occurrence for some unforeseen reasons it
was rescheduled, that means to change VDT in another
week of the month, the same local, day and period but
in another week (alternates venues were not used to re-
place cancelled sampling events).
Data collection was planned from between two to six
months during 2013–2014 depending on the country in
question. The decision of exactly when to commence
was based on negotiations between the project partner
and collaborating partner and informed by the findings
from the FR. In the final stage three of the randomisa-
tion, eligible men were sampled at selected venues in
accordance with the monthly calendar with the aim to
collect data from eight men.
Respondent-driven sampling
RDS [22] was used to recruit representative samples of
MSM linked to the gay community in each selected city
(Verona, Vilnius, Bucharest, and Bratislava). This specific
approach has been used in previous studies [23–25] tar-
geting different sub-groups or populations (e.g.: MSM,
sexual workers, IDUs) and has been shown to be a reli-
able method for gathering both behavioural and bio-
logical data in hidden or ‘hard-to-reach’ populations.
As with TLS, formative research was conducted prior
to data collection in collaboration with local gay NGOs
in each participating city in order to properly identify
potential interview sites, incentives (amount and type of
incentive), expected network size in the selected city, as
well as characteristics of the network structures. Accord-
ing to the RDS literature, for a sample size of 400 between
six to eight seeds should be selected. For the present
study, five MSM seeds were selected in collaboration with
the local gay NGO (NGO representatives and/or MSM
recruited in gay venues were designated as seeds by the
project team). A specific training session for seeds was
organised in each city, where the project aims and
methodology were explained, including confidentiality
and other ethical issues arising.
Selected seeds were requested to identify and recruit
peers from their social network. For this purpose, each
seed was given three’recruitment coupons’, containing a
unique identification number (barcode), address of the
interview location, as well as the names and contacts of
the research team. A dedicated software package was
developed by the research team in order to generate and
print the recruitment coupons (including the identifica-
tion barcode). This software was designed specifically for
generating and managing barcodes to be read using a
barcode reader, in order to avoid any potential mistake
in the process of code management.
A primary and a secondary incentive were delivered
according to the RDS approach [26]. In order to receive
the secondary incentive (an incentive for each recruited
peer), each participant was required to recruit a maximum
of three eligible peers, and each of the recruited peers was
required to take part in the survey.
Trained health professionals were involved in the col-
lection of the biological sample (serum) in each sites,
whilst trained project staff was involved in the collection
of the behavioural information (questionnaire, additional
items on the network size information), as well as in the
coupon distribution process.
The screener (project staff ) clarified the project goals
and methodology, ensuring that each participant met the
eligibility requirements. Participants were also provided
with a short document containing all the information
related to the survey. After signing the consent form, the
self-administered behavioural questionnaire was pre-
sented to the participant and on completion, pre-test
counselling was provided according to local standard
procedures. A biological sample was then collected by
the project team following the local procedures. All bio-
logical samples were labelled with the participant’s iden-
tification number and sent to the laboratory for analysis.
Participants were provided with the appropriate incen-
tive as well as with three numbered coupons (with a spe-
cific code number). Instructions on how to select
members of the social network were delivered. Finally,
the participant was invited to come back to pick-up the
results of the tests using a card reporting his unique
code. When results were given, a post-test counselling
was offered according to local and WHO standards.
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Laboratory testing
In line with the scientific literature [27–29], the algo-
rithms for laboratory testing were developed taking into
account both the international gold-standards for STI
testing and the local laboratory procedures in each coun-
try, as well as the WHO-STI surveillance guidelines.
TLS study
HIV antibodies were tested in oral fluid samples using a
non-invasive collection method. To collect oral fluid
sample, saliva collection devices (ORACOL; Malvern
Medical Developments, Worcester, UK) were used. After
collection, oral fluid samples were kept between 4 °C
and 8 °C and sent to the laboratory for HIV/AIDS in the
respective countries no more than 72 hours after collec-
tion. Before testing the samples were processed according
to the manufacturer’s procedure.
HIV-antibody testing on the oral fluid samples was
performed according to the manufacturer’s instructions
of GENSCREEN HIV 1/2 version 2, BIO-RAD. All HIV-
reactive samples were re-tested with Vironostika HIV
Ag/Ab, Biomerieux and double sample volume of oral
fluid compared to serum was used for oral fluid testing
(the antigen component of the test was not supposed to
react if oral fluid samples are used). In the case of an
HIV-reactive result in one or both tests, participants
who came back for their test results were encouraged
during post-test counselling to be re-tested from blood
according to the algorithm for RDS study. As a quality
control, for each oral fluid sample, a total IgG antibodies
ELISA test Human IgG ELISA Kit 1x96, Quantitative/
Immunology Consultants Laboratory was used in order
to assess the sample suitability for testing. Before testing,
each sample was diluted 1/250 by a recovery buffer.
Samples below 3.5 titre (cut-off ) were excluded from the
study as being invalid.
RDS study
Serum samples collected through the RDS method were
tested for HIV, HVB, HCV and Syphilis in each country
by EC marked commercial diagnostic kits following
usual testing guidelines. Serum samples were tested first
with an HIV 4th generation ELISA test. For newly diag-
nosed individuals, positive results were confirmed from
the second sample by a Western Blot. Participants with
HIV-positive results were counselled and subsequently
referred into local care systems for further management
of their HIV status. HIV-positive samples were shipped
to a central laboratory under refrigerated conditions for
Avidity Index calculation.
In terms of STI testing, for HBV infections all samples
were tested in each participating country following usual
testing guidelines for HBsAg, anti-HBcAb total and anti-
HBsAb testing. According to the tests results and to a
detailed interpretation of the Hepatitis parameters, a
prompt referral of participants to a reference centre for
further management of their status was ensured. For
HCV infection all samples were tested in each participat-
ing country following usual testing guidelines. Screening
testing was performed with ELISA anti-HCV diagnostic
kits and HCV reactive samples were confirmed using line/
strip immunoassays. Participants with positive results
were referred into the local care systems for further evalu-
ation of their status. Finally, for Syphilis, collected serum
samples were tested in each participating country using
treponemal and non-treponemal tests. Each sample was
tested by both RPR and TPHA qualitative test to assist in
the interpretation of results. In the case of reactive results
RPR and/or TPHA quantitative tests were performed. Par-
ticipants with reactive results were referred into the local
care systems for further evaluating the need for treatment.
Prevention activities
HIV and STI surveillance for both TLS and RDS have
been implemented within the broader context of the
Sialon II prevention activities. HIV/STI prevention and
testing promotion activities are theoretically grounded in
two theoretical concepts, i.e. the Minority Stress Model
[30] and the Information-Motivation-Behavioural skills
model (IMB) [31]. While the former multilevel model,
which predicts health outcomes among minority groups
such as MSM has contextual relevance, the latter targets
individual, cognitive and motivational factors. The devel-
opment of the prevention activities has also been in-
formed by the formative research activities (see above). In
order to ensure comparability across data collection sites,
the Sialon II prevention protocols describe the different
prevention and training activities for field implementation
including: (i) prevention packages (comprising condoms,
lubricants, and leaflets with specifically tailored informa-
tion) which have been developed, designed, and distrib-
uted to the target group throughout the data collection
period, and (ii) interactive peer-to-peer health education
activities that took place at the end of the enrolment
process (or in case the participant declined to be enrolled).
These activities focused on improving knowledge and
building motivation for safer-sex among the participants
along the theoretical dimensions of the IMB model. On
the basis of a series of multiple-choice question cards, par-
ticipants exchanged information on sexual health, HIV/
STI prevention and testing with data collectors/educators
or seeds. In addition (or alternatively depending on the
situation), HIV/STI prevention information has been of-
fered to participants.
As a further support mechanism, a dedicated section
of the Sialon II project website was developed to include
HIV/STI prevention information as well as details of
local voluntary counselling testing (VCT) services. In
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each country, project teams consulted local NGOs with
regards to appropriate ‘MSM friendly’ VCT sites both in
the respective cities and at regional levels. This inventory
informed the final selection of VCT services made avail-
able to respondents through the prevention package.
Moreover, TLS data collectors/educators and RDS-seeds
received a specific training session based on the Sialon II
prevention manual which included information on HIV/
STI prevention and testing, adaptable strategies for dif-
ferent situations and settings to empower participants to
adopt healthy behaviours, and the role of meaningful
HIV/STI surveillance and prevalence data in prevention
activities [17]. For RDS, participants additionally bene-
fited from discussing prevention issues during the pre/
post-test counselling sessions at the participating study
sites.
Ethical issues
In order to comply with all ethical and legal obligations,
in both TLS and RDS surveys the name of the partici-
pant has not been collected. As noted earlier, a unique
barcode was attached to the questionnaire and to the
biological sample for each individual allowing anonymous
linkage between the two kinds of information for later
analysis. Finally, the result of the tests was made available
to the study participants through the same barcode at-
tached to a card given to individuals during the sample
collection.
Participants enrolled in the study were asked to provide
informed consent. Individuals were given the possibility to
withdraw from the study at any time without explanation.
In case of a confirmed positive test, participants were of-
fered a confirmation test on a different biological sample
and encouraged to get a referral to local care for further
checks and treatment in line both with the international
guidelines and local standard pathways of care.
In order to ensure no harm for the respondents en-
rolled in the Sialon II surveys and to harmonise all the
data collection procedures, a specific training manual for
data collectors has been developed. The coordinators
were also in charge of monitoring the local data collec-
tion and coaching the data collectors during activities.
On-going monitoring activities were carried out so that
any potential difficulty or issue in preserving privacy and
confidentiality was supervised.
The Sialon II protocols have been submitted to the
relevant ethics committee in each participating city,
where official approval was obtained prior to any data
collection.
The ethics committee which granted approval were:
Instituut voor Tropische Geneeskunde, Antwerp (Belgium);
National Centre of Infectious and Parasitic Diseases,
Sofia (Bulgaria); Robert Koch Institute Charite, Berlin
(Germany); Azienda Ospedaliera Universitaria Integrata –
Verona University Hospital (Italy); Vilniaus Regioninis
Biomediciciniu Tyrimu Etikos Komitetas Vilnius Medical
University (Lithuania); Komisja Bioetyczna Narodowym
Instytucie Zdrowia Publicznego, Warsaw (Poland);
Conselho de Ética do Instituto de Higiene e Medicina
Tropical, Lisbon (Portugal); Institute Matei Bals, Bucharest
(Romania); Slovak Medical University, Bratislava (Slovakia);
Komisija Republike Slovenije za Medicinsko Etiko,
Ljubljana (Slovenia); German Trias i Puyol Hospital,
Barcelona (Spain); Regionala etikprovningsnamden i
Stockholm (Sweden); Faculty of Health and Social Science
Research Ethics and Governance Committee, University
of Brighton (UK).
Parallel to this process, the protocols were first
submitted to the WHO Research Project Review Panel
(RP2) for the technical approval in 2012, whilst in 2013
the Research Ethics Review Committee (WHO ERC)
was consulted for a special evaluation of the ethical
components. The Sialon II protocols were approved
both by RP2 and by WHO-ERC, thus becoming part of
a WHO collaborating study in February 2013. As a con-
sequence of this, periodical monitoring reports on the
status of the survey implementation have been prepared
and submitted to the WHO-ERC committee for review
and approval.
Data analysis and main results
Data analysis will be carried out in line with the sam-
pling method adopted in each study site. Data manage-
ment will be carried out using DataEntry, R (v3.1.0),
STATA (STATA Statistical Software Release 13, College
Station, TX: StataCorp LP) and SPSS. In line with the
sampling approach adopted, estimates will be weighted.
For RDS, the software used for the analysis will be RDS
Analyst (www.hpmrg.org), a suite of R commands de-
veloped by Mark S. Handcock, Ian E. Fellows, Krista J.
Gile (2015 RDS Analyst: Software for the Analysis of
Respondent-Driven, Sampling Data, Version 0.52). Data
will be analysed as part of the protocol in 2015 and re-
sults will be available in 2016.
Discussion
A second generation surveillance approach to monitor-
ing and controlling the HIV epidemic is a critical tool
for state-of-the art public health. However to-date, adop-
tion of the SGSS approach is far from systematic in
terms of implementation across EU countries. Conse-
quently, reliable, valid and comparable data on undiag-
nosed HIV prevalence related to sexual risk behaviour in
‘hard-to-reach’ populations such as MSM are lacking.
This deficiency is problematic because it leaves a consider-
able gap in terms of the ability of European Member States
to develop and implement targeted and evidence-based
HIV/STI prevention strategies. In order to maximise the
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benefits of SGSS approaches, European Member States
need to harmonise their HIV and STI behavioural sur-
veillance systems through the adoption of a common
set of indicators in comparable SGSS studies targeting
high-risk populations [5].
This paper describes the protocols of the Sialon II project,
the aim of which has been the implementation of a large-
scale bio-behavioural survey among MSM in Europe using
a SGSS approach, as well as the carrying out of meaningful
and targeted HIV/STI prevention. These project protocols
offer an important contribution to the epidemiology of
HIV/STIs as well as European public health more broadly.
Specifically, implementation of the Sialon II protocols,
which take into account the most recent GARPR indicators
[11], offer a unique opportunity to pilot a large-scale bio-
behavioural survey in line with the SGSS approach in a sub-
stantial number of EU countries. The Sialon II protocol and
findings (that will be available on the project website as well
as in additional scientific publications from 2016) are likely
to contribute significantly to increasing the comparability
of data in EU countries through the use of common indica-
tors and in implementing effective public health strategies
and policies in areas of high need. In addition to this, data
collected through the former Sialon project and through
the Sialon II survey could represent the basis for imple-
menting additional surveys – in line with the SGSS – in
order to develop trend analysis to monitor the HIV-STI
epidemic over time.
Two key discrete yet linked elements of the protocols
appear to be particularly valuable for the implementation
of the Sialon II surveillance and prevention programme
including: (i) the use of TLS and RDS methodologies to
access ‘hard-to-reach’ MSM (sub)populations, and (ii) a
project philosophy underpinned by principles of com-
munity based participation. In terms of the former, as
sex between men is often highly stigmatised in many
European countries, MSM can be ‘hard-to-reach’ which
in turn, can make HIV/STI surveillance as well as pre-
vention programmes and/or interventions particularly
challenging to implement and evaluate.
In terms of limitations, the use of two different sampling
strategies could represent a limitation for the study, as it
has been shown in other studies that through TLS and
RDS methods different segments of the total MSM popu-
lation can be enrolled and this can result in different
sample characteristics, and the differences may persist also
after applying weighting corrections to the result esti-
mates: this might limit the results from the Sialon II
survey. However, in Sialon II protocols, the deployment
of TLS and RDS methods have been particularly benefi-
cial, as they represent the most advanced and available
approaches for generating statistically representative
samples from ‘hidden’ and most-at-risk populations (in this
case MSM).
Finally, the Sialon protocols may provide a useful and
feasible model for community-based organisations to
conduct decentralised and de-medicalised HIV testing in
the future, as such protocols were tested across highly
heterogeneous settings. This approach is increasingly
seen as an important strategy to increase coverage of
HIV testing and to de-stigmatise and normalise HIV
testing in the communities, with the aim to contain the
HIV epidemic among MSM.
Conclusions
It is likely that the implementation of the Sialon II proto-
cols will contribute to a better understanding of MSM
HIV/STI prevention needs as well as the existence of gaps
with respect to existing HIV/STI prevention provision.
Moreover, by involving the MSM community in all aspects
of the study through both the partnership itself and collab-
orations with local gay NGOs in the participating coun-
tries, as well as working intersectorally with public health
institutions and universities, it is possible to increase the
capacity of all stakeholders in using innovative sampling
methods for collecting bio- behavioural data among MSM
in future second generation surveys. The data collected
through implementing the protocols may contribute to es-
timating HIV/STI prevalence and undiagnosed infections
in the MSM population, as well as modelling of STI
epidemic patterns, increasing comparability of data in
EU countries and implementing effective public health
strategies and policies in areas of high need.
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